The SRPK inhibitor N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl) isonicotinamide (SRPIN340) increases the immune response against metastatic melanoma in mice

Publication date: Available online 2 July 2022Source: Biochemical PharmacologyAuthor(s): Gabriela Alves Moreira, Mônica Maria Magalhães Caetano, Juliana Alves do Vale, Janine Cerqueira de Paiva, Victor Hugo Sousa Gonçalves, Alisson Andrade Almeida, Luc…